Αρχική World News Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant ICIs... World News Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant ICIs Exceeded Adjuvant Benchmarks Από Ogkologos - 13 Οκτωβρίου, 2026 63 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from updated pooled analysis Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Detection of ctDNA fractions with a single tumour-informed and tumour-agnostic profiling... 27 Οκτωβρίου, 2026 Improved Survival Benefit with Encorafenib plus Cetuximab plus mFOLFOX6 in First-Line... 25 Ιουνίου, 2025 Will politics keep us from accessing EU science funding? 25 Ιουλίου, 2022 Durable Antitumour Activity of Pembrolizumab Plus Lenvatinib in Patients with Previously... 25 Ιουλίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Most Tattoo Artists Want to Show Off Their Work. These Nipple... Oral Cancer Taught Me How Much Words Matter Approval Expanded for Venetoclax in Chronic Lymphocytic Leukemia Professor Ian Tomlinson: “Philanthropy is priceless to science”
